Alk-activated Tumors

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-06-09
Clinical Trial Update: Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK) [Phase 1]
Phase I pediatric trial of LDK378 (alectinib) in ALK-activated tumors; study completed with results posted.